Digital PCR Market by Treatment Type (Droplet Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162602
- 237 Pages
- November 2020
- Pharmaceuticals
Digital polymerase chain reaction (dPCR) is a new approach for detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and others similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique is expected to boost the market growth during the forecast period. However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer remunerative opportunities for market players.
The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
Depending on type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global digital polymerase chain reaction market include Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc. Product launch and acquisition was the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.
KEY BENEFITS FOR STAKEHOLDERS
• This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.
• Quantitative analysis of the current trends and future estimations assist stakeholders to design business strategies accordingly.
• Porter’s five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
• Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
Key Market Segments
• By Treatment Type
o Droplet Digital PCR
o BEAMing Digital PCR
• By Product Type
o Digital PCR Systems
o Consumables & Reagents
o Software & Services
• By Application
o Research
o Clinical Diagnostics
o Forensic & Others
• By End User
o Pharmaceuticals & Biotechnology Industries
o Clinical Diagnostic Laboratories
o Universities & Other Organizations
• By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
List of key players profiled in the report
• 4basebio AG
• Bio-Rad Laboratories, Inc.
• Combinati, Inc.
• Fluidigm Corporation
• JN Medsys
• Merck KGaA
• Qiagen N.V.
• Stilla Technologies
• Sysmex Corporation
• Thermo Fisher Scientific, Inc
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Promega Corporation
• Takara Bio Inc.
• Avance Biosciences Inc.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in prevalence of infectious diseases and cancer
3.5.1.2.Increase in awareness and acceptance of personalized medicines
3.5.1.3.Technological advancements
3.5.2.Restraints
3.5.2.1.High cost of dPCR devices
3.5.2.2.Reimbursement issues
3.5.3.Opportunity
3.5.3.1.Increase in funding for R&D activities
3.6.Impact analysis of COVID-19 on the digital PCR market
CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY
4.1.Overview
4.1.1.Market size and forecast
4.2.Droplet digital PCR
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.BEAMing dPCR
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Consumables & reagents
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Digital PCR systems
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Software & services
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Research
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Clinical diagnostics
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Forensic & others
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Clinical diagnostic laboratories
7.2.1.Market size and forecast
7.2.2.Market analysis, by country
7.3.Pharmaceuticals & biotechnology industries
7.3.1.Market size and forecast
7.3.2.Market analysis, by country
7.4.Universities & other organizations
7.4.1.Market size and forecast
7.4.2.Market analysis, by country
CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION
8.1.OVERVIEW
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.North America digital PCR market, by country
8.2.2.1.U.S. digital PCR market, by technology
8.2.2.2.U.S. digital PCR market, by product type
8.2.2.3.U.S. digital PCR market, by application
8.2.2.4.U.S. digital PCR market, by end user
8.2.2.5.Canada digital PCR market, by technology
8.2.2.6.Canada digital PCR market, by product type
8.2.2.7.Canada digital PCR market, by application
8.2.2.8.Canada digital PCR market, by end user
8.2.2.9.Mexico digital PCR market, by technology
8.2.2.10.Mexico digital PCR market, by product type
8.2.2.11.Mexico digital PCR market, by application
8.2.2.12.Mexico digital PCR market, by end user
8.2.3.North America digital PCR market, by technology
8.2.4.North America digital PCR market, by product type
8.2.5.North America digital PCR market, by application
8.2.6.North America digital PCR market, by end user
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Europe digital PCR market, by country
8.3.2.1.Germany digital PCR market, by technology
8.3.2.2.Germany digital PCR market, by product type
8.3.2.3.Germany digital PCR market, by application
8.3.2.4.Germany digital PCR market, by end user
8.3.2.5.France digital PCR market, by technology
8.3.2.6.France digital PCR market, by product type
8.3.2.7.France digital PCR market, by application
8.3.2.8.France digital PCR market, by end user
8.3.2.9.UK digital PCR market, by technology
8.3.2.10.UK digital PCR market, by product type
8.3.2.11.UK digital PCR market, by application
8.3.2.12.UK digital PCR market, by end user
8.3.2.13.Italy digital PCR market, by technology
8.3.2.14.Italy digital PCR market, by product type
8.3.2.15.Italy digital PCR market, by application
8.3.2.16.Italy digital PCR market, by end user
8.3.2.17.Spain digital PCR market, by technology
8.3.2.18.Spain digital PCR market, by product type
8.3.2.19.Spain digital PCR market, by application
8.3.2.20.Spain digital PCR market, by end user
8.3.2.21.Rest of Europe digital PCR market, by technology
8.3.2.22.Rest of Europe digital PCR market, by product type
8.3.2.23.Rest of Europe digital PCR market, by application
8.3.2.24.Rest of Europe digital PCR market, by end user
8.3.3.Europe digital PCR market, by technology
8.3.4.Europe digital PCR market, by product type
8.3.5.Europe digital PCR market, by application
8.3.6.Europe digital PCR market, by end user
8.4.Asia-Pacific
8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific digital PCR market, by country
8.4.2.1.Japan digital PCR market, by technology
8.4.2.2.Japan digital PCR market, by product type
8.4.2.3.Japan digital PCR market, by application
8.4.2.4.Japan digital PCR market, by end user
8.4.2.5.China digital PCR market, by technology
8.4.2.6.China digital PCR market, by product type
8.4.2.7.China digital PCR market, by application
8.4.2.8.China digital PCR market, by end user
8.4.2.9.Australia digital PCR market, by technology
8.4.2.10.Australia digital PCR market, by product type
8.4.2.11.Australia digital PCR market, by application
8.4.2.12.Australia digital PCR market, by end user
8.4.2.13.India digital PCR market, by technology
8.4.2.14.India digital PCR market, by product type
8.4.2.15.India digital PCR market, by application
8.4.2.16.India digital PCR market, by end user
8.4.2.17.South Korea digital PCR market, by technology
8.4.2.18.South Korea digital PCR market, by product type
8.4.2.19.South Korea digital PCR market, by application
8.4.2.20.South Korea digital PCR market, by end user
8.4.2.21.Taiwan digital PCR market, by technology
8.4.2.22.Taiwan digital PCR market, by product type
8.4.2.23.Taiwan digital PCR market, by application
8.4.2.24.Taiwan digital PCR market, by end user
8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user
8.4.3.Asia-Pacific digital PCR market, by technology
8.4.4.Asia-Pacific digital PCR market, by product type
8.4.5.Asia-Pacific digital PCR market, by application
8.4.6.Asia-Pacific digital PCR market, by end user
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.LAMEA digital PCR market, by country
8.5.2.1.Brazil digital PCR market, by technology
8.5.2.2.Brazil digital PCR market, by product type
8.5.2.3.Brazil digital PCR market, by application
8.5.2.4.Brazil digital PCR market, by end user
8.5.2.5.Saudi Arabia digital PCR market, by technology
8.5.2.6.Saudi Arabia digital PCR market, by product type
8.5.2.7.Saudi Arabia digital PCR market, by application
8.5.2.8.Saudi Arabia digital PCR market, by end user
8.5.2.9.South Africa digital PCR market, by technology
8.5.2.10.South Africa digital PCR market, by product type
8.5.2.11.South Africa digital PCR market, by application
8.5.2.12.South Africa digital PCR market, by end user
8.5.2.13.Rest of LAMEA digital PCR market, by technology
8.5.2.14.Rest of LAMEA digital PCR market, by product type
8.5.2.15.Rest of LAMEA digital PCR market, by application
8.5.2.16.Rest of LAMEA digital PCR market, by end user
8.5.3.LAMEA digital PCR market, by technology
8.5.4.LAMEA digital PCR market, by product type
8.5.5.LAMEA digital PCR market, by application
8.5.6.LAMEA digital PCR market, by end user
CHAPTER 9:COMPANY PROFILES
9.1.BIO-RAD LABORATORIES, INC.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.4BASEBIO AG
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business Performance
9.3.COMBINATI, INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments
9.4.FLUIDIGM CORPORATION
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.JN MEDSYS
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments
9.6.MERCK KGAA
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.QIAGEN N.V.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segment
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.SYSMEX CORPORATION
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.STILLA TECHNOLOGIES
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments
9.10.THERMO FISHER SCIENTIFIC, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
TABLE 01.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 02.DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.BEAMING PCR MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 05.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 06.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY REGION, 2019–2027 ($MILLION)
TABLE 07.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 2019–2027 ($MILLION)
TABLE 10.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 11.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 13.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 14.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2019–2027 ($MILLION)
TABLE 15.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 16.DIGITAL PCR MARKET REVENUE, BY REGION, 2019–2027($MILLION)
TABLE 17.NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 18.U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 19.U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 20.U.S. DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 21.U.S. DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 22.CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 23.CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 24.CANADA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 25.CANADA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 26.MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 27.MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 28.MEXICO DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 29.MEXICO DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 30.NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 31.NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 32.NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 33.NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 34.EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 35.GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 36.GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 37.GERMANY DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 38.GERMANY DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 39.FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 40.FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 41.FRANCE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 42.FRANCE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 43.UK DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 44.UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 45.UK DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 46.UK DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 47.ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 48.ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 49.ITALY DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 50.ITALY DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 51.SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 52.SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 53.SPAIN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 54.SPAIN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 55.REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 56.REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 57.REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 58.REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 59.EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 60.EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 61.EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 62.EUROPE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 64.JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 65.JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 66.JAPAN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 67.JAPAN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 68.CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 69.CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 70.CHINA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 71.CHINA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 73.AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 74.AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 75.AUSTRALIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 77.INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 78.INDIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 79.INDIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 80.SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 81.SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 82.SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 83.SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 84.TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 85.TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 86.TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 87.TAIWAN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 88.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 89.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 90.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 91.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 92.ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 93.ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 94.ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 95.ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 96.LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 97.BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 98.BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 99.BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 100.BRAZIL DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 101.SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 102.SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 103.SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 104.SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 105.SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 106.SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 107.SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 108.SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 109.REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 110.REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 111.REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 112.REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 113.LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 114.LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 115.LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 116.LAMEA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 117.BIO-RAD: COMPANY SNAPSHOT
TABLE 118.BIO-RAD: OERATING SEGMENT
TABLE 119.BIO-RAD: PRODUCT PORTFOLIO
TABLE 120.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.4BASEBIO: COMPANY SNAPSHOT
TABLE 122.4BASEBIO: PRODUCT PORTFOLIO
TABLE 123.COMBINATI: COMPANY SNAPSHOT
TABLE 124.COMBINATI: PRODUCT PORTFOLIO
TABLE 125.COMBINATI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126.FLUIDIGM: COMPANY SNAPSHOT
TABLE 127.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 128.JN MEDSYS: COMPANY SNAPSHOT
TABLE 129.JN MEDSYS: PRODUCT PORTFOLIO
TABLE 130.MERCK: COMPANY SNAPSHOT
TABLE 131.MERCK: OPERATING SEGMENTS
TABLE 132.MERCK: PRODUCT PORTFOLIO
TABLE 133.QIAGEN: COMPANY SNAPSHOT
TABLE 134.QIAGEN: PRODUCT SEGMENT
TABLE 135.QIAGEN: PRODUCT PORTFOLIO
TABLE 136.SYSMEX: COMPANY SNAPSHOT
TABLE 137.SYSMEX: OERATING SEGMENT
TABLE 138.SYSMEX.: PRODUCT PORTFOLIO
TABLE 139.STILLA: COMPANY SNAPSHOT
TABLE 140.STILLA: PRODUCT PORTFOLIO
TABLE 141.THERMO FISHER: COMPANY SNAPSHOT
TABLE 142.THERMO FISHER.: OERATING SEGMENT
TABLE 143.THERMO FISHER.: PRODUCT PORTFOLIO
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
